Limit search to available items
Nearby Subjects are:
Result Page   Prev Next
Add Marked to Bag Add All On Page Add Marked to My Lists
Mark   Year Entries
 

Immunotherapies, Adoptive -- See Immunotherapy, Adoptive


Form of adoptive transfer where cells with antitumor activity are transferred to the tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL). This is usually considered a form of passive immunotherapy. (From DeVita, et al., Cancer, 1993, pp.305-7, 314)
  1
 

Immunotherapies, Adoptive Cellular -- See Immunotherapy, Adoptive


Form of adoptive transfer where cells with antitumor activity are transferred to the tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL). This is usually considered a form of passive immunotherapy. (From DeVita, et al., Cancer, 1993, pp.305-7, 314)
  1
 

Immunotherapies, Allergen -- See Desensitization, Immunologic


Immunosuppression by the administration of increasing doses of antigen. Though the exact mechanism is not clear, the therapy results in an increase in serum levels of allergen-specific IMMUNOGLOBULIN G, suppression of specific IgE, and an increase in suppressor T-cell activity
  1
 

Immunotherapies, Passive -- See Immunization, Passive


Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER)
  1
  Immunotherapy -- 3 Related Subjects   3
Immunotherapy.   89
Immunotherapy, Active.   3
Immunotherapy, Active -- methods. : Immunologic adjuvant research / Antonio H. Benvenuto, editor  2009 1
Immunotherapy, Adoptive.   2
 

Immunotherapy, Adoptive Cellular -- See Immunotherapy, Adoptive


Form of adoptive transfer where cells with antitumor activity are transferred to the tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL). This is usually considered a form of passive immunotherapy. (From DeVita, et al., Cancer, 1993, pp.305-7, 314)
  1
 

Immunotherapy, Allergen -- See Desensitization, Immunologic


Immunosuppression by the administration of increasing doses of antigen. Though the exact mechanism is not clear, the therapy results in an increase in serum levels of allergen-specific IMMUNOGLOBULIN G, suppression of specific IgE, and an increase in suppressor T-cell activity
  1
Allergy -- Immunotherapy.   7
Asthma -- Immunotherapy.   2
Autoimmune diseases -- Immunotherapy.   2
Brain -- Tumors -- Immunotherapy. : Translational immunotherapy of brain tumors / edited by John H. Sampson  2017 1
Cancer -- Immunotherapy.   46
Cancer -- Immunotherapy -- Periodicals : Journal for immunotherapy of cancer  2013- 1
Immunotherapy -- Congresses. : Immunotherapy in 2020 : visions and trends for targeting inflammatory disease / A. Radbruch [and others], editors  2007 1
Diabetes -- Immunotherapy. : Development of immunotherapies for type 1 diabetes : value and limitations of mouse models / Matthias von Herrath  2015 1
Diabetes -- Immunotherapy -- Congresses. : Defining optimal immunotherapies for type 1 diabetes  2008 1
Immunotherapy -- Electronic Journals : International immunopharmacology (Online)  2001- 1
Immunotherapy -- ethics. : New treatments for addiction : behavioral, ethical, legal, and social questions / Committee on Immunotherapies and Sustained-Release formations for Treating Drug Addiction ; Henrick J. Harwood and Tracy G. Myers, editors  2004 1
Gastrointestinal system -- Cancer -- Immunotherapy. : Immunotherapy for gastrointestinal cancer / David Kerr, Rebecca Johnson, editors  2017 1
Gliomas -- Immunotherapy. : Glioma : immunotherapeutic approaches / edited by Ryuya Yamanaka  2012 1
Immunotherapy -- Handbooks, manuals, etc   2
HIV infections -- Immunotherapy. : Soluble factors mediating innate immune responses to HIV infection / edited by Massimo Alfano  2010 1
Immunotherapy -- legislation & jurisprudence. : New treatments for addiction : behavioral, ethical, legal, and social questions / Committee on Immunotherapies and Sustained-Release formations for Treating Drug Addiction ; Henrick J. Harwood and Tracy G. Myers, editors  2004 1
Leukemia -- Immunotherapy. : Novel treatment options in lymphoma and leukemia : part 2 of 2 / Nishitha M. Reddy  2017 1
Lymphomas -- Immunotherapy. : Novel treatment options in lymphoma and leukemia : part 2 of 2 / Nishitha M. Reddy  2017 1
Melanoma -- Immunotherapy.   4
Immunotherapy -- methods.   26
Multiple sclerosis -- Immunotherapy. : Multiple sclerosis immunology : a foundation for current and future treatments / Takashi Yamamura, Bruno Gran, editors  2013 1
Mycoses -- Immunotherapy. : Antifungal agents : methods and protocols / edited by Erika J. Ernst and P. David Rogers  2005 1
 

Immunotherapy, Passive -- See Immunization, Passive


Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER)
  1
Immunotherapy -- Periodicals   23
Immunotherapy -- trends   6
Immunotherapy -- veterinary : Equine clinical immunology / [edited by] M. Julia B. Felippe  2016 1
 

Immunotoxicity -- See Immunotoxicology


  1
  Immunotoxicology -- 2 Related Subjects   2
Immunotoxicology.   9
Immunotoxicology -- Periodicals   3
Immunotoxicology -- Research -- Methodology. : Investigative immunotoxicology / edited by Helen Tryphonas [and others]  2005 1
 

Immunotoxin -- See Immunotoxins


Semisynthetic conjugates of various toxic molecules, including RADIOACTIVE ISOTOPES and bacterial or plant toxins, with specific immune substances such as IMMUNOGLOBULINS; MONOCLONAL ANTIBODIES; and ANTIGENS. The antitumor or antiviral immune substance carries the toxin to the tumor or infected cell where the toxin exerts its poisonous effect
  1
 

Immunotoxins -- See Antibody-toxin conjugates


  1
Immunotoxins.   6
Immunotoxins -- adverse effects.   4
Immunotoxins -- pharmacokinetics. : Fusion protein technologies for biopharmaceuticals : applications and challenges / edited by Stefan R. Schmidt  2013 1
Immunotoxins -- pharmacology.   3
Immunotoxins -- therapeutic use.   4
Immunstimulation : Immunonutrition : interactions of diet, genetics, and inflammation / edited by Bharat B. Aggarwal, David Heber  2014 1
Add Marked to Bag Add All On Page Add Marked to My Lists
Result Page   Prev Next